Aegea Biotechnologies, Inc. Announces the Issuance of US Patent for Primer-Switch Nucleic Acid Probes for the Detection of Rare Genetic Events and for PCR Amplification Improvements – PRNewswire

21st August 2020

Aegea Biotechnologies, Inc. Announces the Issuance of US Patent for Primer-Switch Nucleic Acid Probes for the Detection of Rare Genetic Events and for PCR Amplification Improvements PRNewswire